Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
7.81M
-
Shares change
-
+7.81M
-
Total reported value, excl. options
-
$94.4M
-
Value change
-
+$94.4M
-
Number of buys
-
24
-
Price
-
$12.09
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q4 2017
24 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q4 2017.
scPharmaceuticals Inc. - Common Stock (SCPH) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.81M shares
of 53.4M outstanding shares and own 14.63% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.41M shares), RA CAPITAL MANAGEMENT, LLC (2.86M shares), PRICE T ROWE ASSOCIATES INC /MD/ (305K shares), FMR LLC (200K shares), Vanguard Group Inc (180K shares), Alyeska Investment Group, L.P. (175K shares), AWM Investment Company, Inc. (165K shares), Nicholas Investment Partners, LP (124K shares), Bain Capital Public Equity Management, LLC (107K shares), and DAFNA Capital Management LLC (98.1K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.